Pediatric diabetes consortium T1D New Onset ( NeOn ) study: clinical outcomes during the first year following diagnosis
dc.contributor.author | Cengiz, Eda | en_US |
dc.contributor.author | Connor, Crystal G | en_US |
dc.contributor.author | Ruedy, Katrina J | en_US |
dc.contributor.author | Beck, Roy W | en_US |
dc.contributor.author | Kollman, Craig | en_US |
dc.contributor.author | Klingensmith, Georgeanna J | en_US |
dc.contributor.author | Tamborlane, William V | en_US |
dc.contributor.author | Lee, Joyce M | en_US |
dc.contributor.author | Haller, Michael J | en_US |
dc.date.accessioned | 2014-06-04T14:57:06Z | |
dc.date.available | WITHHELD_13_MONTHS | en_US |
dc.date.available | 2014-06-04T14:57:06Z | |
dc.date.issued | 2014-06 | en_US |
dc.identifier.citation | Cengiz, Eda; Connor, Crystal G; Ruedy, Katrina J; Beck, Roy W; Kollman, Craig; Klingensmith, Georgeanna J; Tamborlane, William V; Lee, Joyce M; Haller, Michael J (2014). "Pediatric diabetes consortium T1D New Onset ( NeOn ) study: clinical outcomes during the first year following diagnosis." Pediatric Diabetes 15(4): 287-293. | en_US |
dc.identifier.issn | 1399-543X | en_US |
dc.identifier.issn | 1399-5448 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/107374 | |
dc.description.abstract | Objective There have been few prospective, multicenter studies investigating the natural history of type 1 diabetes ( T1D ) from the time of diagnosis. The objective of this report from the Pediatric Diabetes Consortium ( PDC ) T1D New Onset ( NeOn ) study was to assess the natural history and clinical outcomes in children during the first year after diagnosis of T1D . Research design and methods: Clinical measures from the first year following diagnosis were analyzed for 857 participants (mean age 9.1 yr, 51% female, 66% non‐Hispanic White) not participating in an intervention study who had a HbA1c result at 12 months. Results Mean HbA1c ± SD was 102 ± 25 mmol/mol (11.4 ± 2.3%) at diagnosis, 55 ± 12 mmol/mol (7.2 ± 1.1%) at 3 months, 56 ± 15 mmol/mol (7.3 ± 1.3%) at 6 months and 62 ± 16 mmol/mol (7.8 ± 1.5%) at 12 months from diagnosis. A severe hypoglycemic ( SH ) event occurred in 31 (4%) participants (44 events, 5.2 events per 100 person‐years). Diabetic ketoacidosis ( DKA ) not including diagnosis occurred in 10 (1%) participants (13 events, 1.5 events per 100 person‐years). Conclusions After onset of T1D , mean HbA1c reaches its nadir at 3–6 months with a gradual increase through 12 months. SH and DKA are uncommon but still occur during the first year with T1D . Data from large cohorts, such as the PDC T1D NeOn study, provide important insights into the course of T1D during the first year following diagnosis, which will help to inform the development of models to target future interventions. | en_US |
dc.publisher | John Wiley & Sons A/S | en_US |
dc.subject.other | Children | en_US |
dc.subject.other | Diabetes | en_US |
dc.subject.other | HbA1c or Glycemic Control | en_US |
dc.title | Pediatric diabetes consortium T1D New Onset ( NeOn ) study: clinical outcomes during the first year following diagnosis | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Pediatrics | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/107374/1/pedi12068.pdf | |
dc.identifier.doi | 10.1111/pedi.12068 | en_US |
dc.identifier.source | Pediatric Diabetes | en_US |
dc.identifier.citedreference | Salemyr J, Bang P, Örtqvist E. Lower HbA1c after 1 year, in children with type 1 diabetes treated with insulin glargine vs NPH insulin from diagnosis: a retrospective study. Pediatr Diabetes. 2011: 12: 501 – 505. | en_US |
dc.identifier.citedreference | Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long‐term complications in insulin‐dependent diabetes mellitus. N Engl J Med 1993: 329: 977 – 986. | en_US |
dc.identifier.citedreference | Diabetes Control and Complications Trial Research Group. Effect of intensive diabetes treatment on the development and progression of long‐term complications in adolescents with insulin‐dependent diabetes mellitus: Diabetes Control and Complications Trial. J Pediatr 1994: 125: 177 – 188. | en_US |
dc.identifier.citedreference | Martin CL, Albers J, Herman WH et al. Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion. Diabetes Care 2006: 29: 340 – 344. | en_US |
dc.identifier.citedreference | Metzger M, Leibowitz G, Wainstein J, Glaser B, Raz I. Reproducibility of glucose measurements using the glucose sensor. Diabetes Care 2002: 25: 1185 – 1191. | en_US |
dc.identifier.citedreference | Beck RW, Tamborlane WV, Bergenstal RM, Miller KM, DuBose SN, Hall CA. The T1D Exchange Clinic Registry. J Clin Endocrinol Metab 2012: 97: 4383 – 4389. | en_US |
dc.identifier.citedreference | American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2011: 34 ( Suppl. 1 ): S62 – 69. | en_US |
dc.identifier.citedreference | Pediatric Diabetes Consortium. The pediatric diabetes consortium: improving care of children with type 1 diabetes through collaborative research. Diabetes Technol Ther 2010: 12: 685 – 688. | en_US |
dc.identifier.citedreference | Kuczmarski R, Ogden C, Grummer‐Strawn L et al. CDC growth charts: United States. Adv Data 2000: 314: 1 – 27. | en_US |
dc.identifier.citedreference | Mortensen HB, Hougaard P, Swift P et al. New definition for the partial remission period in children and adolescents with type 1 diabetes. Diabetes Care 2009: 32: 1384 – 1390. | en_US |
dc.identifier.citedreference | Couper JDK. Phases of diabetes in children and adolescents. Pediatr Diabetes 2009: 10: 13 – 16. | en_US |
dc.identifier.citedreference | Lombardo FVM, Wasniewska M, Messina MF, Ruggeri C, Arrigo T, De Luca F. Two‐year prospective evaluation of the factors affecting honeymoon frequency and duration in children with insulin dependent diabetes mellitus: the key‐role of age at diagnosis. Diabetes Nutr Metab 2002: 15: 246 – 251. | en_US |
dc.identifier.citedreference | Writing Group for the SEARCH for Diabetes in Youth Study Group, Dabelea D, Bell R et al. Incidence of diabetes in youth in the United States. JAMA 2007: 297: 2716 – 2724. | en_US |
dc.identifier.citedreference | Mortensen HB, Swift PG, Holl RW et al. Multinational study in children and adolescents with newly diagnosed type 1 diabetes: association of age, ketoacidosis, HLA status, and autoantibodies on residual beta‐cell function and glycemic control 12 months after diagnosis. Pediatr Diabetes 2010: 11: 218 – 226. | en_US |
dc.identifier.citedreference | Ramchandani N, Ellis MK, Jain S et al. Basal insulin requirements on continuous subcutaneous insulin infusion during the first 12 months after diagnosis of type 1 diabetes mellitus. J Diabetes Sci Technol 2010: 4: 610 – 614. | en_US |
dc.identifier.citedreference | Beck JK, Lewis TV, Logan KJ, Harrison DL, Gardner AW, Copeland KC. Intensive vs. conventional insulin management initiated at diagnosis in children with diabetes: should payer source influence the choice of therapy? Pediatr Diabetes 2009: 10: 368 – 373. | en_US |
dc.identifier.citedreference | Bowden SA, Duck MM, Hoffman RP. Young children (<5 yr) and adolescents (>12 yr) with type 1 diabetes mellitus have low rate of partial remission: diabetic ketoacidosis is an important risk factor. Pediatr Diabetes 2008: 9: 197 – 201. | en_US |
dc.identifier.citedreference | Chase HP, MacKenzie TA, Burdick J et al. Redefining the clinical remission period in children with type 1 diabetes. Pediatr Diabetes 2004: 5: 16 – 19. | en_US |
dc.identifier.citedreference | Palta M, Shen G, Allen C, Klein R, D'Lessio D, the Wisconsin Diabetes Registry. Longitudinal Patterns of Glycemic Control and Diabetes Care from Diagnosis in a Population‐based Cohort with Type 1 Diabetes. Am J Epidemiol 1996: 144: 954 – 961. | en_US |
dc.identifier.citedreference | Yki‐Järvinen H, Koivisto V. Insulin sensitivity in newly diagnosed type 1 diabetics after ketoacidosis and after three months of insulin therapy. J Clin Endocrinol Metab 1984: 59: 371 – 378. | en_US |
dc.identifier.citedreference | Yki‐Järvinen H, Koivisto V. Natural course of insulin resistance in type I diabetes. N Engl J Med 1986: 315: 224 – 230. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.